The field of cancer biology is rapidly moving from an era of specialization to an era of integration.  New high-throughput methods to molecularly characterize cancer cells have, in recent years, lead to tremendous strides in the development of novel diagnostics and the identification of new molecular targets for therapeutic intervention. On the computational side, recently developed algorithms customized for the analysis of genomic, proteomic and other high volume datasets are providing a level of insight into cellular complexities never before imagined. The number of new technologies and devices arising from the fields of biomedical engineering and nanotechnology that have potential application to the area of cancer biology is unprecedented.

We are at a truly exciting crossroads in the history of cancer research where molecular biology, the computational sciences, engineering and nanotechnology are joining together in a unified effort to develop more effective cancer diagnostics and therapeutics.  The benefits of this integrated approach are only beginning to be realized. The future potential of these collaborative efforts cannot be overstated.


Georgia Tech has been a leader in the development of collaborative approaches to both cancer diagnostics and therapeutics. The mission of the Integrated Cancer Research Center (ICRC) is to facilitate integration of the diversity of technological, computational, scientific and medical expertise at Georgia Tech and partner institutions in a coordinated effort to develop improved cancer diagnostics and therapeutics.